FINWIRES · TerminalLIVE
FINWIRES

Valero Refinery Recovery Gains Pace Post-Blast; Key Units Resume, Wood Mackenzie Says

By

-- Valero Energy's (VLO) 415,000 b/d Port Arthur refinery is gradually restoring operations more than a month after a Mar. 23 explosion disrupted output, Wood Mackenzie said Thursday.

The blast damaged the diesel hydrotreater DHT-243, forcing a plant-wide shutdown and triggering phased recovery efforts as operators began restarting select processing units.

Wood Mackenzie tracked progress using aerial surveillance and infrared monitoring, which showed reconstruction underway alongside sequential unit restarts across the facility, it said.

The refinery restarted its fluid catalytic cracker on Apr. 26 and began ramping up its largest crude unit the same day, though utilization remains below normal levels, Wood Mackenzie added.

Operators have ramped up major units, including a 265,000 b/d crude distillation unit and a 172,000 b/d vacuum distillation unit, which are currently increasing throughput, though not yet at full capacity.

Several units have restarted, including a 150,000 b/d CDU and a 48,000 b/d VDU on April 2; hydrocrackers of 57,000 b/d and 45,000 b/d on April 3 and April 15; and an 80,000 b/d FCC on April 26, while a 47,000 b/d diesel hydrotreater and a sulfur recovery unit remain offline.

The explosion also disrupted the adjacent Diamond Green renewable diesel plant, which depends on refinery utilities, though it resumed operations later in March, Wood Mackenzie added.

Initial damage assessments showed the diesel hydrotreater sustained the most severe impact, with collapsed structures and extensive piping deformation across the unit.

Nearby units experienced lighter damage, while two cooling towers and a control room within the blast zone suffered more significant structural impacts, Wood Mackenzie said.

Repair crews have focused on rebuilding the cooling towers, with cranes, scaffolding, and dismantling work visible as contractors replaced damaged components.

Despite progress, multiple units remained offline as of Apr. 27, including parts of the refinery's largest crude distillation system, limiting output recovery, according to Wood Mackenzie.

The prolonged outage has tightened regional fuel markets, as the loss of 415,000 b/d capacity coincides with geopolitical tensions affecting global supply balances, Wood Mackenzie added.

Wood Mackenzie said its combined aerial and field monitoring will continue tracking restart timelines and operational recovery across the refinery.

Related Articles

Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Moderna, Inc. After Q1 Earnings

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:After reviewing Q1 results, we up our target to $48 from $39, based on our NPV analysis. We widen our 2026 LPS view to -$7.95 from -$7.16 and keep our 2027 LPS view at -$4.82. MRNA reported a strong Q1, exceeding revenue expectations and demonstrating significant Y/Y growth. During the analyst call, management highlighted key regulatory approvals in Europe for its respiratory vaccine portfolio and oncology pipeline advancements, which we find encouraging. Despite a GAAP net loss widened by a one-time litigation settlement, underlying financial discipline and cost reduction efforts are noteworthy. Yet, revenue guidance for Q2 is relatively low at $50M-$100M (CFRA: $92M), which points to a 65%-30% Y/Y deceleration (CFRA: 35%) but also signals a significant swing Q/Q after the company recorded $153M in sales in Q1. While we think the progress in the oncology pipeline with the partnership with Merck & Co. (MRK 112 ****) is promising and progressing well, we continue to view MRNA as a wait and see story.

$MRNA
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ge Healthcare Technologies Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $65 from $87, based on 11.8x our 2027 EPS estimate of $5.51, a sharp discount to the stock's average forward P/E of 18.1x. We cut our 2026 adjusted EPS estimate to $4.86 from $4.96, which stands at the lower end of the reduced guidance range of $4.80-$5.00 (vs. previous $4.95-$5.15). GEHC achieved Q1 organic revenue growth of 2.9% Y/Y, which was at the high end of its expectations. Yet profitability metrics were disappointing with adjusted EPS of $0.99 missing expectations, and the adjusted EBIT margin declining 150 bps Y/Y. This was primarily due to a discrete supplier issue in the PDx business and an unexpected increase in inflationary costs. As a result, GEHC lowered its profit and cash flow outlook, which we view as a prudent move. Strategically, we think GEHC is advancing a strong innovation pipeline, has completed the acquisition of Intelerad, and has announced a reorganization to combine its Imaging and AVS segments into a new segment, which has the potential to accelerate growth.

$GEHC
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Lennox International Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target to $569 from $559, 21.4x our 2027 EPS estimate (down to $26.57 from $26.62; our 2026 estimate down to $24.14 from $24.51), near LII's three- and five-year historical forward averages of 21.9x and 20.6x, respectively. We think LII faces material near-term operational challenges from residential market softness, escalating tariff-driven cost inflation (~5% vs. prior ~2.5% guidance), and margin compression in its Home Comfort Solutions segment (390-bp decline to 13.3% in Q1). However, these concerns are substantially mitigated by the Building Climate Solutions segment's exceptional performance (38% revenue growth, 300-bp margin expansion to 19.7% in Q1), significantly improved operating cash flow ($16.1M vs. -$35.8M Y/Y) due to inventory normalization. We note an antitrust class action lawsuit, filed in March, alleging price-fixing among HVAC equipment manufacturers since January 2020, posing an additional risk to LII's financial and reputational standing.

$LII